Keros Therapeutics, Inc.
KROS | US
Overview
Corporate Details
- ISIN(s):
- US4923271013
- LEI:
- Country:
- United States of America
- Address:
- 1050 WALTHAM STREET, SUITE 302, 2421 LEXINGTON
- Website:
- https://www.kerostx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Keros Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Keros Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Keros Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
United States of America
VOR
CRO for pharma & med devices specializing in safety info, PMS & full lifecycle support.
Japan
7079
Japan
7079
Develops advanced antibody-drug conjugates (ADCs) for difficult-to-treat cancers.
United States of America
WHWK
United States of America
WHWK
Integrated R&D platform offering CRO services, lab construction, and biotech incubation.
South Korea
215380
South Korea
215380
Develops tech for laundry/apparel to cut water use and capture microplastic pollution.
United Kingdom
XSG
United Kingdom
XSG
Engineering tumor-activated biologics for cancer to maximize efficacy and minimize toxicity.
United States of America
XLO
United States of America
XLO
Develops stem cell therapies for osteoarthritis and venous leg ulcers using proprietary technology.
Sweden
XINT
Sweden
XINT
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland
XLS
Switzerland
XLS
Develops novel antibody cancer therapies using proprietary T-cell engager & antibody library tech.
South Korea
338840
South Korea
338840
Developing blood-based cancer detection and regenerative therapies for biopharma partners.
United States of America
YDES
United States of America
YDES